-
1
-
-
0027958452
-
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor
-
Samal B, Sun Y, Stearns G, [et al.]. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994, 14, 1431-1437.
-
(1994)
Mol Cell Biol
, vol.14
, pp. 1431-1437
-
-
Samal, B.1
Sun, Y.2
Stearns, G.3
-
2
-
-
25844491778
-
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
-
Berndt J, Klöting N, Kralisch S, [et al.]. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005, 54, 2911-2916.
-
(2005)
Diabetes
, vol.54
, pp. 2911-2916
-
-
Berndt, J.1
Klöting, N.2
Kralisch, S.3
-
3
-
-
33846991610
-
Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation
-
Varma V, Yao-Borengasser A, Rasouli N, [et al.]. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab. 2007, 92, 666-672.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 666-672
-
-
Varma, V.1
Yao-Borengasser, A.2
Rasouli, N.3
-
4
-
-
33644826101
-
Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin
-
Curat C, Wegner V, Sengenes C, [et al.]. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 2006, 49, 744-747.
-
(2006)
Diabetologia
, vol.49
, pp. 744-747
-
-
Curat, C.1
Wegner, V.2
Sengenes, C.3
-
5
-
-
0035062540
-
Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes
-
Ognjanovic S, Bao S, Yamamoto S, [et al.]. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol. 2001, 26, 107-117.
-
(2001)
J Mol Endocrinol
, vol.26
, pp. 107-117
-
-
Ognjanovic, S.1
Bao, S.2
Yamamoto, S.3
-
6
-
-
0036795752
-
Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes
-
Ognjanovic S, Bryant-Greenwood G. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes Am J Obstet Gynecol. 2002, 187, 1051-1058.
-
(2002)
Am J Obstet Gynecol
, vol.187
, pp. 1051-1058
-
-
Ognjanovic, S.1
Bryant-Greenwood, G.2
-
7
-
-
0036856578
-
Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyl- transferase, a cytosolic enzyme involved in NAD biosynthesis
-
Rongvaux A, Shea R, Mulks M, [et al.]. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyl- transferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol. 2002, 32, 3225-3234.
-
(2002)
Eur J Immunol
, vol.32
, pp. 3225-3234
-
-
Rongvaux, A.1
Shea, R.2
Mulks, M.3
-
8
-
-
35549002189
-
Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme
-
Revollo J, Korner A, Mills K, [et al.]. Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 2007, 6, 363-375.
-
(2007)
Cell Metab
, vol.6
, pp. 363-375
-
-
Revollo, J.1
Korner, A.2
Mills, K.3
-
9
-
-
33749436629
-
Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes
-
Haider D, Pleiner J, Francesconi M, [et al.]. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab. 2006, 91, 4702- 4704.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 4702-4704
-
-
Haider, D.1
Pleiner, J.2
Francesconi, M.3
-
10
-
-
33750867485
-
Serum visfatin increases with progressive beta-cell deterioration
-
López-Bermejo A, Chico-Julia B, Fern_ndez-Balsells M, [et al.]. Serum visfatin increases with progressive beta-cell deterioration. Diabetes. 2006, 55, 2871-2875.
-
(2006)
Diabetes
, vol.55
, pp. 2871-2875
-
-
López-Bermejo, A.1
Chico-Julia, B.2
Fernandez-Balsells, M.3
-
11
-
-
30344471828
-
Elevated plasma level of visfatin/pre-B cell colony- enhancing factor in patients with type 2 diabetes mellitus
-
Chen M, Chung F, Chang D, [et al.]. Elevated plasma level of visfatin/pre-B cell colony- enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006, 91, 295-299.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 295-299
-
-
Chen, M.1
Chung, F.2
Chang, D.3
-
12
-
-
33846930861
-
Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance
-
Dogru T, Sonmez A, Tasci I, [et al.]. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract. 2007, 76, 24-29.
-
(2007)
Diabetes Res Clin Pract
, vol.76
, pp. 24-29
-
-
Dogru, T.1
Sonmez, A.2
Tasci, I.3
-
13
-
-
33847629715
-
Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance
-
Fernández-Real J, Moreno J, Chico B, [et al.]. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care. 2007, 30, 616-621.
-
(2007)
Diabetes Care
, vol.30
, pp. 616-621
-
-
Fernández-Real, J.1
Moreno, J.2
Chico, B.3
-
14
-
-
33644821728
-
Visfatin is an adipokine, but it is not regulated by thiazolidinediones
-
Hammarstedt A, Pihlajamäki J, Rotter Sopasakis V, [et al.]. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab. 2006, 91, 1181-1184.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 1181-1184
-
-
Hammarstedt, A.1
Pihlajamäki, J.2
Rotter Sopasakis, V.3
-
15
-
-
33846138616
-
Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects
-
Li L, Yang G, Li Q, [et al.]. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes. 2006, 114, 544-548.
-
(2006)
Exp Clin Endocrinol Diabetes
, vol.114
, pp. 544-548
-
-
Li, L.1
Yang, G.2
Li, Q.3
-
16
-
-
33646052892
-
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding
-
Haider D, Schindler K, Schaller G, [et al.]. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 2006, 91, 1578-1581.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 1578-1581
-
-
Haider, D.1
Schindler, K.2
Schaller, G.3
-
17
-
-
34347402227
-
Serum concentration of visfatin in obese women
-
Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, [et al.]. Serum concentration of visfatin in obese women. Metabolism. 2007, 56, 1131-1134.
-
(2007)
Metabolism
, vol.56
, pp. 1131-1134
-
-
Zahorska-Markiewicz, B.1
Olszanecka-Glinianowicz, M.2
Janowska, J.3
-
18
-
-
33747745349
-
Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans
-
Pagano C, Pilon C, Olivieri M, [et al.]. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab. 2006, 91, 3165-3170.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 3165-3170
-
-
Pagano, C.1
Pilon, C.2
Olivieri, M.3
-
19
-
-
33846900883
-
Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function
-
Fasshauer M, Blüher M, Stumvoll M, [et al.]. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf). 2007, 66, 434-443.
-
(2007)
Clin Endocrinol (Oxf)
, vol.66
, pp. 434-443
-
-
Fasshauer, M.1
Blüher, M.2
Stumvoll, M.3
-
20
-
-
45349099943
-
Serum levels of the adipokine visfatin are increased in pre-eclampsia
-
Fasshauer M, Waldeyer T, Seeger J, [et al.]. Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf). 2008, 69, 69-73.
-
(2008)
Clin Endocrinol (Oxf)
, vol.69
, pp. 69-73
-
-
Fasshauer, M.1
Waldeyer, T.2
Seeger, J.3
-
21
-
-
33745243693
-
Decreased plasma visfatin concentrations in women with gestational diabetes mellitus
-
Chan T, Chen Y, Lee C, [et al.] Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Invest. 2006, 13, 364-367.
-
(2006)
J Soc Gynecol Invest
, vol.13
, pp. 364-367
-
-
Chan, T.1
Chen, Y.2
Lee, C.3
-
22
-
-
34447124952
-
Visfatin response to glucose is reduced in women with gestational diabetes mellitus
-
Haider D, Handisurya A, Storka A, [et al.]. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care. 2007, 30, 1889-1891.
-
(2007)
Diabetes Care
, vol.30
, pp. 1889-1891
-
-
Haider, D.1
Handisurya, A.2
Storka, A.3
-
23
-
-
33646707249
-
Increased visfatin concentrations in women with gestational diabetes mellitus
-
Krzyzanowska K, Krugluger W, Mittermayer F, [et al.]. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Science (Lond). 2006, 110, 605-609.
-
(2006)
Clin Science (Lond)
, vol.110
, pp. 605-609
-
-
Krzyzanowska, K.1
Krugluger, W.2
Mittermayer, F.3
-
24
-
-
34147127510
-
Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degree of glucose tolerance
-
Lewandowski K, Stojanovic N, Press M, [et al.] Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degree of glucose tolerance. Diabetologia. 2007, 50, 1033-1037.
-
(2007)
Diabetologia
, vol.50
, pp. 1033-1037
-
-
Lewandowski, K.1
Stojanovic, N.2
Press, M.3
-
25
-
-
0031851293
-
Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
-
Alberti K, Zimmet P. Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15, 539- 553.
-
(1998)
Diabet Med
, vol.15
, pp. 539-553
-
-
Alberti, K.1
Zimmet, P.2
-
26
-
-
0027517862
-
Metabolic changes in gestational diabetes
-
Carpenter M. Metabolic changes in gestational diabetes. Clin Perinatol. 1993, 20, 583- 591.
-
(1993)
Clin Perinatol
, vol.20
, pp. 583-591
-
-
Carpenter, M.1
-
27
-
-
34547631993
-
The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity
-
Mastorakos G, Valsamakis G, Papatheodorou D, [et al.]. The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem. 2007, 53, 1477-1483.
-
(2007)
Clin Chem
, vol.53
, pp. 1477-1483
-
-
Mastorakos, G.1
Valsamakis, G.2
Papatheodorou, D.3
-
28
-
-
33745789837
-
The release of the adipocytokine visfatin is regulated by glucose and insulin
-
Haider D, Schaller G, Kapiotis S, [et al.]. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia. 2006, 49, 1909-1914.
-
(2006)
Diabetologia
, vol.49
, pp. 1909-1914
-
-
Haider, D.1
Schaller, G.2
Kapiotis, S.3
|